World Investment Advisors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1652594
SANTA BARBARA, CA
Position in VRTX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$812,702
-$81,323 QoQ
Shares Held
1,820
-7.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026World Investment Advisors holds $5,395,760 across 16 Biotechnology names. VRTX ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GERN |
Geron Corp
|
1,033,779 | $1,540,330 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,820 | $812,702 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
845 | $652,880 | |
| 4 | RPRX |
Royalty Pharma plc
|
9,949 | $477,253 | |
| 5 | MRNA |
Moderna, Inc.
|
6,999 | $355,549 | |
| 6 | INCY |
Incyte Corp
|
3,471 | $326,690 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
4,978 | $321,728 | |
| 8 | DMAC |
DiaMedica Therapeutics Inc.
|
36,975 | $250,320 |
All Filings in VRTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $812,702 | 1,820 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $894,025 | 1,972 | Shares | Sole | 2026-03-13 | |
| 2025-09-30 | $560,436 | 1,431 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $557,834 | 1,253 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $423,732 | 874 | Shares | Sole | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||